可编程释放的多种蛋白质药物从aptamer-functionalized水凝通过核酸杂交通过核酸杂交
Mark R Battig1, Boonchoy Soontornworajit, Yong Wang
1Department of Chemical, Materials, and Biomolecular Engineering, University of Connecticut, Storrs, Connecticut 06269, United States.
Journal of the American Chemical Society
|July 24, 2012
概括
这项研究引入了aptamer功能化的水凝,用于控制的多阶段蛋白质药物释放. 生物分子触发器使复杂疾病的治疗可调节的释放率.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 分子生物学分子生物学
背景情况:
- 聚合物输送系统对于局部和受控的蛋白质药物释放至关重要.
- 实现多种蛋白质药物的分别分阶段释放仍然是治疗开发中的重大挑战.
研究的目的:
- 开发一种新的聚合物输送系统,用于可编程,多阶段释放多种蛋白质药物.
- 为了证明使用具有互补序列的aptamer功能化水凝作为受控蛋白质释放的触发器.
主要方法:
- 用特定的体制造功能化的水凝.
- 利用互补序列 (CSs) 作为生物分子触发器来启动蛋白质释放.
- 研究阿巴,蛋白质药物和CS之间的特定序列相互作用,以控制释放动力学.
主要成果:
- 成功地证明了蛋白质药物的多阶段释放从aptamer功能化水凝.
- 使用CS触发器在预先确定的时间点实现可调节的释放速度.
- 证实了阿巴-蛋白结合和阿巴-CS杂交的序列特异性.
结论:
- 阿普塔默功能化水凝为可编程释放多种蛋白质药物提供了一个有希望的平台.
- 该系统能够精确控制药物释放动力学,适应疾病进展.
- 潜在的应用包括治疗复杂的人类疾病,需要多阶段的治疗干预.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


